The 2-Minute Rule for Conolidine Proleviate for Joint Pain Treatment
Conolidine’s analgesic results stem from its interaction with non-opioid pain pathways. Compared with opioids, which bind to µ-opioid receptors from the central nervous technique, conolidine modulates alternate molecular targets. A Science Advances analyze uncovered that conolidine interacts While using the atypical chemokine receptor ACKR3/CXCR